Back to Search
JOSEPH MCMURRAY, D.M.D.
D.M.D.
NPI: 1730288671Individual
Specialties, Licenses & Credentials
Oral & Maxillofacial Surgery (D.M.D.)Primary
Oral & Maxillofacial Surgery
Code: 204E00000X
38331(CA)
Research & Publications (20)
Design of the Reduction of Events with Darbepoetin alfa in Heart Failure (RED-HF): a Phase III, anaemia correction, morbidity-mortality trial.
PMID 19633103·Eur J Heart Fail·2009
3-trial
The European Register of Specialists in Clinical Chemistry and Laboratory Medicine: Code of Conduct, Version 2--2008.
PMID 19676151·Clin Chem Lab Med·2009
8-other
Inhibition of Stat3 by cell-permeable peptidomimetic prodrugs targeted to its SH2 domain.
PMID 19400306·Adv Exp Med Biol·2009
8-other
Model of intermolecular interactions between high affinity phosphopeptides and Stat3.
PMID 19400305·Adv Exp Med Biol·2009
8-other
Heart failure with preserved ejection fraction: clinical characteristics of 4133 patients enrolled in the I-PRESERVE trial.
PMID 18279770·Eur J Heart Fail·2008
2-rct
Structural basis for the binding of high affinity phosphopeptides to Stat3.
PMID 18058821·Biopolymers·2008
8-other
Long-term safety and effectiveness of sildenafil citrate in men with erectile dysfunction.
PMID 18516312·Ther Clin Risk Manag·2007
8-other
Effects of tezosentan on symptoms and clinical outcomes in patients with acute heart failure: the VERITAS randomized controlled trials.
PMID 17986694·JAMA·2007
4-observational
Relationship of dose of background angiotensin-converting enzyme inhibitor to the benefits of candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM)-Added trial.
PMID 16644319·Am Heart J·2006
8-other
The effect of valsartan, captopril, or both on atherosclerotic events after acute myocardial infarction: an analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT).
PMID 16487836·J Am Coll Cardiol·2006
8-other
Treatment of chronic heart failure: a comparison between the major guidelines.
PMID 16820365·Eur Heart J·2006
4-observational
Resource utilization and costs in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme.
PMID 16754631·Eur Heart J·2006
4-observational
Chronic kidney disease in patients with cardiac disease: a review of evidence-based treatment.
PMID 16164616·Kidney Int·2005
6-review
Antiarrhythmic effect of carvedilol after acute myocardial infarction: results of the Carvedilol Post-Infarct Survival Control in Left Ventricular Dysfunction (CAPRICORN) trial.
PMID 15708698·J Am Coll Cardiol·2005
3-trial
Practical recommendations for the use of ACE inhibitors, beta-blockers, aldosterone antagonists and angiotensin receptor blockers in heart failure: putting guidelines into practice.
PMID 16087129·Eur J Heart Fail·2005
8-other
What are the clinical consequences of anemia in patients with chronic heart failure?
PMID 15007794·J Card Fail·2004
6-review
Treatment of heart failure with spironolactone--trial and tribulations.
PMID 15295043·N Engl J Med·2004
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 7880 WREN AVE, SUITE# E-152
GILROY, CA 95020 - Phone
- (408) 847-6725
Quick Facts
- NPI
- 1730288671
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile